The Trifecta valve is constructed using a polyester and tissue-covered titanium stent, or base.
The valve features leaflets manufactured from pericardial tissue attached to the exterior of the valve stent.
The design allows the leaflets to open fully, mimicking the performance of a healthy aortic heart valve and limiting tissue abrasion through tissue-to-tissue (stent-to-leaflet) contact.
The valve offers the St Jude Medical’s patented Linx AC Technology, an anticalcification treatment designed to reduce tissue mineralization (hardening), one of the primary causes of valve deterioration.
St Jude Medical Cardiovascular Division president Frank Callaghan said Trifecta has demonstrated hemodynamic performance and has improved the lives of patients with aortic valve disease.
